-
8 Oppenheimer Analysts Choose Their Favorite Healthcare Stocks
Tuesday, March 31, 2015 - 12:04pm | 463Read More...In a recent report, Oppenheimer asked analysts that cover different areas of the stock market each to choose his or her single top stock pick in the space based on the company's fundamentals. Here are the stocks that Oppenheimer's eight analysts in the healthcare sector chose as top...
-
UPDATE: Oppenheimer Downgrades Computer Programs & Systems on Lofty Expectations
Wednesday, October 16, 2013 - 9:24am | 166Read More...In a report published Wednesday, Oppenheimer analyst Bret Jones downgraded the rating on Computer Programs & Systems (NASDAQ: CPSI) from Outperform to Perform, and removed the $57.00 price target. In the report, Oppenheimer noted, “We are downgrading the shares of CPSI to Perform in part...
-
Brean Murray, Carret Suspends Phase Forward (PFWD) Coverage
Wednesday, April 28, 2010 - 12:11pm | 107Read More...Brean Murray, Carret and Co. analyst Bret Jones said that because of the pending acquisition of Phase Forward Incorporated (NASDAQ: PFWD) by Oracle Corporation (NASDAQ: ORCL) , his firm was suspending coverage of the company until the deal closes. The acquisition is expected to be finalized before...
-
Brean Murray Carrett & Co. Issues Earnings Preview for Allscripts-Misys Healthcare Solutions (NASDAQ: MDRX)
Monday, April 5, 2010 - 10:48am | 175Read More...With Allscripts-Misys (NASDAQ: MDRX) set to report 3QFY10 results on Wednesday, Brean Murray Carrett & Co. rate the stock as Buy and give a price target of $21. An analyst for the firm states, “We are looking for a modest sequential uptick in bookings this quarter and believe bookings will...
